Acoustic percussive device treats cellulite, augments contouring | Clothing, fitness trends drive rising labiaplasty demand | How to safely disagree with customers
March 20, 2018
In the News
Acoustic percussive device treats cellulite, augments contouring
Zimmer's acoustic percussive device is among plastic surgeons' latest options for cellulite reduction, and it might help reduce swelling and promote lymphatic drainage. The device can also enhance results of cryolipolysis, liposuction, abdominoplasty and neck lift, says plastic surgeon Gordon Sasaki.
Modern Medicine/The Aesthetic Channel (3/19) 
LinkedIn Twitter Facebook Google+ Email
Clothing, fitness trends drive rising labiaplasty demand
The rising popularity of so-called athleisure clothing as well as fitness classes based on stationary bicycles have combined to boost demand for labiaplasty, not only for aesthetic reasons but also for the sake of comfort, says plastic surgeon David Cangello. The procedure is relatively minor and can be performed under local anesthesia, and full recovery takes about a month, Cangello says.
The Independent (London) (tiered subscription model) (3/15) 
LinkedIn Twitter Facebook Google+ Email
Dr. Clark Schierle on the Power of Canfield’s 3D Imaging
Showing a client before and after images in 2D is good, but 3D is much more powerful. The number one thing compelling the patient to come in is the ability to see their personal results in 3D. Seeing themselves in 3D is what closes the deal. Learn more.
Practice Management
How to safely disagree with customers
When you don't agree with customers, it's important to first give credit to their ideas before asking permission to explore other options, writes Ken Sterling. After doing so, you can explain why other options make more sense without offending the customer, he writes.
Inc. online (3/14) 
LinkedIn Twitter Facebook Google+ Email
Health Quality & Advocacy
Experimental nonopioid reduces surgical pain in 2 clinical trials
Heron Therapeutics' HTX-011 reduced pain and allowed patients undergoing bunionectomy or hernia repair to avoid postoperative opioid pain drugs in two Phase III clinical trials, and the company plans to request FDA approval for the drug. The drug, which was injected at the surgical site and is comprised of bupivacaine with meloxicam, was superior to bupivacaine alone and to a placebo in both trials, the company says.
The San Diego Union-Tribune (tiered subscription model) (3/19) 
LinkedIn Twitter Facebook Google+ Email
Experts: Delay surgical excision of heterotopic ossification
Heterotopic ossification, or the ectopic production of mature bone in nonskeletal tissue, is associated with burns, neurologic injury, musculoskeletal trauma and orthopedic surgery and is not always limited to the injury site. Nonsurgical management and prevention options include aggressive stretching, radiotherapy, pulsed low-intensity electromagnetic field therapy and indomethacin. Surgical excision should be postponed until radiographic evidence of HO maturation and should be supplemented with bisphosphonate therapy, write plastic surgeon Wyatt Payne and colleagues.
Medscape (free registration)/ePlasty (3/14) 
LinkedIn Twitter Facebook Google+ Email
Research & Technology
Experimental dyes glow in cancerous cells
Experimental dyes that collect in cancerous cells and glow upon exposure to near-infrared light might help surgeons find and remove cancer cells during surgery. The technique could help prevent the need for follow-up surgery in patients with breast and other cancers, says National Cancer Institute imaging specialist Paula Jacobs.
WCBS-TV (New York City) (3/14) 
LinkedIn Twitter Facebook Google+ Email
It is the same with people as it is with riding a bike. Only when moving can one comfortably maintain one's balance.
Albert Einstein,
theoretical physicist
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy policy |  Legal Information